Cerity Partners LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1566475 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,589,207

+$484,475 QoQ

Shares Held

40,488

-7.4% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#86

of 264 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 0% Shared 70% None 30%

Healthcare · as of Jun 30, 2026

Cerity Partners LLC holds $67,490,391 across 30 Drug Manufacturers - Specialty & Generic names. KNSA ranks #8 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	123,778	$20,861,543
2	UTHR	UNITED THERAPEUTICS Corp	20,210	$10,950,383
3	ZTS	Zoetis Inc.	90,284	$6,487,806
4	VTRS	Viatris Inc	280,668	$4,457,007
5	HLN	Haleon plc	443,467	$4,137,546
6	TEVA	Teva Pharmaceutical Industries Ltd	106,508	$3,608,490
7	RDY	Dr Reddys Laboratories Ltd	184,772	$2,677,345
8	KNSA	Kiniksa Pharmaceuticals International, plc This page	40,488	$2,589,207

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,589,207	40,488	-7.4%	Shares	Other	2026-08-14
2026-03-31	$2,104,732	43,712	+1.1%	Shares	Other	2026-05-15
2025-12-31	$1,782,783	43,219	+0.4%	Shares	Sole	2026-02-11
2025-09-30	$1,671,087	43,036	+2.7%	Shares	Other	2025-10-22
2025-06-30	$1,159,483	41,904	+2.9%	Shares	Other	2025-08-13
2025-03-31	$904,124	40,708	+42.3%	Shares	Sole	2025-04-30
2024-12-31	$565,668	28,598	-14.3%	Shares	Sole	2025-02-13
2024-09-30	$834,266	33,384	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.